Skip to main content

Table 3 Tumor characteristics of patients between non-LNM and LNM groups

From: Risk factors for lymph node metastasis in gastric neuroendocrine tumor: a retrospective study

 

Non-LNM

(n = 37)

LNM

(n = 82)

P-value

Tumor size (cm)

4.44 ± 3.81

5.37 ± 2.54

0.120

Tumor size classification (n, %)

  

0.062

 < 5 cm

27 (73.0%)

45 (54.9%)

 ≥ 5 cm

10 (27.0%)

37 (45.1%)

G grade (n, %)

  

0.210

 G1

3 (8.3%)

5 (6.1%)

 G2

0 (0.0%)

4 (4.88%)

 G3

22 (61.1%)

59 (72.0%)

 NEC

11 (30.6%)

14 (17.1%)

Tumor location (n, %)

  

0.005*

 Cardia and fundus of stomach

16 (43.2%)

46 (56.3%)

 Body of stomach

9 (24.3%)

30 (36.6%)

 Pyloric antrum

7 (18.9%)

5 (6.5%)

 Pyloric canal

5 (13.5%)

1 (1.2%)

CD56 (n, %)

  

0.177

 –

9 (27.3%)

15 (21.9%)

 + 

12 (36.4%)

32 (46.4%)

 ++ 

8 (24.2%)

7 (10.1%)

 +++ 

4 (12.1%)

15 (21.7%)

 Unknown

4 (12.1%)

13 (15.9%)

Ki67

43.3 ± 27.6%

58.3 ± 21.6%

0.002*

Syn (n, %)

  

0.405

 –

0

1 (1.2%)

 + 

14 (37.8%)

22 (26.8%)

 ++ 

5 (13.5%)

20 (24.4%)

 +++ 

17 (45.9%)

37 (45.1%)

 Unknown

1 (2.7%)

2 (2.4%)

CgA (n, %)

  

0.045*

 –

9 (24.4%)

22 (26.8%)

 + 

14 (37.8%)

31 (37.8%)

 ++ 

0

11 (13.4%)

 +++ 

13 (35.1%)

15 (18.3%)

 Unknown

1 (2.7%)

3 (3.7%)

  1. *The asterisk indicates statistical significance